CT Dose Simulation Study for Appendicitis
Launched by SEOUL NATIONAL UNIVERSITY BUNDANG HOSPITAL · Sep 20, 2015
Trial Information
Current as of August 20, 2025
Completed
Keywords
ClinConnect Summary
Three sequential non-inferiority tests are planned. First, three readers will review the original 2-mSv images. Second, the readers will review the 75%-dose images. After the readers review the 75%-dose images and before the readers reviewed the 50%-dose images, the non-inferiority of 75% dose to the original dose will be tested. If the non-inferiority is not accepted, the study will be terminated with the conclusion of 2 mSv as the lowest acceptable dose. If the non-inferiority is accepted, the study will be continue to the next step. In the same manner, the readers will review the next lo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18-44 years of age.
- • Emergency department visit with suspected symptoms and signs of acute appendicitis
- • Intravenous contrast-enhanced computed tomography examination requested due to suspicion of appendicitis
- Exclusion Criteria:
- • having contraindications of intravenous contrast agent
About Seoul National University Bundang Hospital
Seoul National University Bundang Hospital is a leading academic medical center located in South Korea, renowned for its commitment to innovative research and excellence in patient care. As a sponsor of clinical trials, the hospital leverages its extensive expertise in various medical fields, employing cutting-edge technologies and methodologies to advance healthcare solutions. With a multidisciplinary team of skilled researchers and clinicians, the hospital aims to enhance clinical outcomes through rigorous investigation and collaboration, contributing significantly to the global medical community and improving patient lives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seongnam Si, Gyeonggi Do, Korea, Republic Of
Patients applied
Trial Officials
Ji Hoon Park, MD
Principal Investigator
Seoul National University Bundang Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials